Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Tests an added heart procedure during balloon ablation for persistent atrial fibrillation

Tests adding left atrial appendage isolation to balloon ablation in adults with persistent atrial fibrillation.

Plain-language title generated from the registry record
Registry title: Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standing Persistent Atrial Fibrillation

Key facts

Where
Hamburg and Lübeck, GermanySee the 3 sites

Where in Germany

  • Asklepios Klinik AltonaHamburg, GermanyTaking people
  • University Hospital Eppendorf, Hamburg, GermanyHamburg, GermanyTaking people
  • Clinic for Rhythmologiy Luebeck, Schleswig-Holstein GermanyLübeck, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Luebeck
Trial code
NCT04240366
Record updated
29 August 2024
Original description
Additional left atrial appendage isolation during balloon ablation for persistent or long-standing persistent atrial fibrillation can reduce atrial fibrillation reoccurrence within 3-12 months compared to balloon-based pulmonary vein isolation only.Read full original descriptionShow less

Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standing Persistent Atrial Fibrillation

Additional left atrial appendage isolation during balloon ablation for persistent or long-standing persistent atrial fibrillation can reduce atrial fibrillation reoccurrence within 3-12 months compared to balloon-based pulmonary vein isolation only.

Inclusion: Persistent or long-standing persistent AF (i.e. continuous AF that was/is sustained >7 days or >12 months, respectively); Age ≥18 and ≤80 years; Indication for AF ablation as per current guidelines.

Exclusion: Previous pulmonary vein isolation or MAZE surgery; Previous led atrial appendage closure or surgical excision; Long-standing persistent atrial fibrillation with a continuous AF duration of >4 years; Missing informed consent; LAA diameter >25mm 10mm distant from circumflex artery assessed by TEE; Paroxysmal atrial fibrillation; Left atrial diameter >60 mm at baseline; Left atrial thrombus at baseline.

ClinicalTrials.gov NCT04240366